BTS

41 days ago

Regarding prolific lying: when did Stuart Ashman start being even more honest about how the June placing cash would be spent?

Bearded Geordie poltroon Stuart Ashman says without citing one actual example that I am a “prolific liar.” The overpaid and under-delivering CEO of Skinbiotherapeutics (SBTX) thinks that he always tells the truth. Let’s rewind to June 16th when shareholders were 10% diluted in a £4.2 million placing.

49 days ago

Stuart Ashman and a new rodent interview – surely AIM Regulation cannot allow this?

Stuart Ashman, the incompetent in charge at Skinbiotherapeutics (SBTX) recorded a podcast with the sycophantic poltroon Lemming yesterday in which he made statements which surely AIM Regulation must be all over. This is just not the way a CEO should conduct himself, even if the audience is only 23, as the maths just does not stack up.

86 days ago

Explaining IFRS and Revenue Recognition to a Lemming re Skinbiotherapeutics

In an attempt to polish the turd which was the failure of Skinbiotherapeutics (SBTX) to ‘fess that it would miss revenue forecasts for the year to June 30 2025 by a country mile before doing a placing on 16 June, comrade Lemming makes an excuse in the comments section on this website which fails to appreciate IFRS Revenue recognition Rules.